128 related articles for article (PubMed ID: 5407058)
1. Interaction of aromatic amines with rat-liver proteins in vivo. 3. On the mechanism of binding of the carcinogens, N-2-fluorenylacetamide and N-hydroxy-2-fluorenyl-acetamide, to the soluble proteins.
Barry EJ; Malejka-Giganti D; Gutmann HR
Chem Biol Interact; 1969 Dec; 1(2):139-55. PubMed ID: 5407058
[No Abstract] [Full Text] [Related]
2. Further evidence for two types of adducts of N-hydroxy-2-fluorenylacetamide with rat-liver proteins.
Barry EJ; Gutmann HR
Chem Biol Interact; 1970 Aug; 2(2):158-9. PubMed ID: 5526729
[No Abstract] [Full Text] [Related]
3. The conversion of the carcinogen N-hydroxy-2-fluorenylacetamide to o-amidophenols by rat liver in vitro.
Gutmann HR; Erickson RR
J Biol Chem; 1972 Feb; 247(3):660-6. PubMed ID: 5058220
[No Abstract] [Full Text] [Related]
4. Possible role of the glucuronide conjugate in the biochemical mechanism of binding of the carcinogen N-hydroxy-2-acetylaminofluorene to rat-liver deoxyribonucleic acid in vivo.
Irving CC; Veazey RA; Russell LT
Chem Biol Interact; 1969 Oct; 1(1):19-26. PubMed ID: 5407052
[No Abstract] [Full Text] [Related]
5. Depression of enzymic esterification of N-hydroxy-AAF in the liver during aminoazo dye carcinogenesis in the rat.
Blunck JM; Lees BJ
Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):421-9. PubMed ID: 4699475
[No Abstract] [Full Text] [Related]
6. Persistent binding of a new reaction product of the carcinogen N-hydroxy-N-2-acetylaminofluorene with guanine in rat liver DNA in vivo.
Kriek E
Cancer Res; 1972 Oct; 32(10):2042-8. PubMed ID: 5080759
[No Abstract] [Full Text] [Related]
7. Reactivities of the carcinogens, N-hydroxy-2-fluorenylacetamide and N-hydroxy-3-fluorenylacetamide, with tissue nucleophiles.
Zieve FJ; Gutmann HR
Cancer Res; 1971 Apr; 31(4):471-6. PubMed ID: 5553692
[No Abstract] [Full Text] [Related]
8. Inhibitors of chemical carcinogens as probes for molecular targets: DNA as decisive receptor for metabolite from N-hydroxy-N-2-fluorenylacetamide.
Matsushima T; Weisburger JH
Chem Biol Interact; 1969 Dec; 1(2):211-21. PubMed ID: 5407060
[No Abstract] [Full Text] [Related]
9. On the correlation between the hepatocarcinogenicity of the carcinogen, N-2-fluorenylacetamide, and its metabolic activation by the rat.
Gutmann HR; Malejka-Giganti D; Barry EJ; Rydell RE
Cancer Res; 1972 Jul; 32(7):1554-61. PubMed ID: 4337834
[No Abstract] [Full Text] [Related]
10. Methylmercapto-4-acetylaminostilbenes as products of the reaction of n-acetoxy-4-acetylaminostilbene with methionine and as degradation products of liver protein from rats given n-hydroxy-4-acetylaminostilbene.
Miller EC; Butler BW; Fletcher TL; Miller JA
Cancer Res; 1974 Sep; 34(9):2232-9. PubMed ID: 4843530
[No Abstract] [Full Text] [Related]
11. Enzyme-catalyzed reactions of the carcinogen N-hydroxy-2-fluorenylacetamide with nucleic acid.
King CM; Phillips B
Science; 1968 Mar; 159(3821):1351-3. PubMed ID: 5644261
[TBL] [Abstract][Full Text] [Related]
12. Interaction of aromatic amines with rat liver proteins in vivo. I. Preferential labeling of a cytoplasmic protein or proteins by N-2-fluorenyl-acetamide-9-14C.
Barry EJ; Gutmann HR
J Biol Chem; 1966 Oct; 241(20):4600-9. PubMed ID: 5926171
[No Abstract] [Full Text] [Related]
13. On the mechanism of protein binding of N-2-fluorenylacetamide. The deacetylation of N-(1-hydroxy-2-fluorenyl)-acetamide and the effect of ethionine.
GUTMANN HR; SEAL US; IRVING CC
Cancer Res; 1960 Aug; 20():1072-8. PubMed ID: 13830474
[No Abstract] [Full Text] [Related]
14. Acetylation of the carcinogen N-hydroxy-2-acetylaminofluorene by acetyl Coenzyme A to form a reactive ester.
Lotlikar PD; Luha L
Mol Pharmacol; 1971 Jul; 7(4):381-8. PubMed ID: 5113233
[No Abstract] [Full Text] [Related]
15. On the mechanism of action of carcinogenic aromatic amines. I. Binding of 2-acetylaminofluorene and N-hydroxy-2-acetylaminofluorene to rat-liver nucleic acids in vivo.
Kriek E
Chem Biol Interact; 1969 Oct; 1(1):3-17. PubMed ID: 5407054
[No Abstract] [Full Text] [Related]
16. Interaction of aromatic amines with rat liver proteins in vivo. II. Binding of N-2-fluorenylacetamide-9-14C to nuclear proteins.
Barry EJ; Ovechka CA; Gutmann HR
J Biol Chem; 1968 Jan; 243(1):51-60. PubMed ID: 5635948
[No Abstract] [Full Text] [Related]
17. Binding of radioactive N-hydroxy-acetylaminofluorene to synthetic polyribonucleotides.
Marroquin F; Coyote N
Chem Biol Interact; 1970 Aug; 2(2):151-3. PubMed ID: 5526728
[No Abstract] [Full Text] [Related]
18. Modifications of ribonucleic acid by chemical carcinogens. I. In vitro modification of transfer ribonucleic acid by N-acetoxy-2-acetylaminofluorene.
Fink LM; Nishimura S; Weinstein IB
Biochemistry; 1970 Feb; 9(3):496-502. PubMed ID: 4906322
[No Abstract] [Full Text] [Related]
19. Effect of the antioxidant butylated hydroxytoluene (BHT) on the metabolism of the carcinogens N-2-fluorenylacetamide and N-hydroxy-N-2-fluorenylacetamide.
Grantham PH; Weisburger JH; Weisburger EK
Food Cosmet Toxicol; 1973 Apr; 11(2):209-17. PubMed ID: 4716799
[No Abstract] [Full Text] [Related]
20. Isolation and identification of the carcinogen N-hydroxy-2-fluorenylacetamide and related compounds by liquid chromatography.
Gutmann HR
Anal Biochem; 1974 Apr; 58(2):469-78. PubMed ID: 4827393
[No Abstract] [Full Text] [Related]
[Next] [New Search]